References
- Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1-3.
- Harnett JD, Parfrey PS, Kennedy M, Zeldis JB, Steinman TI, Guttmann RD. The long-term outcome of hepatitis B infection in hemodialysis patients. Am J Kidney Dis 1988;11:210-213. https://doi.org/10.1016/S0272-6386(88)80151-3
- Arora S, Siddiqui M, Ali M, et al. Aspartate aminotransferase and alanine aminotransferase levels in hemodialysis patients with positive hepatitis B/hepatitis C serology: are they good predictors of liver injury? Clin Gastroenterol Hepatol 2011;9:185.
- Nam SW, Jung JJ, Bae SH, et al. Clinical outcomes of delayed clearance of serum HBsAg in patients with chronic HBV infection. Korean J Intern Med 2007;22:73-76. https://doi.org/10.3904/kjim.2007.22.2.73
- Piazza V, Efficace E, Montagna G, et al. Spontaneous hepatitis B surface antigen clearance in patients on chronic haemodialysis. Nephrol Dial Transplant 1996;11:1489-1490. https://doi.org/10.1093/ndt/11.7.1489
- Cao YL, Wang SX, Zhu ZM. Hepatitis B viral infection in maintenance hemodialysis patients: a three year follow-up. World J Gastroenterol 2007;13:6037-6040. https://doi.org/10.3748/wjg.13.6037
- Patel C, Monga D, Alexander M, et al. Spontaneous clearance of hepatitis B surface antigenemia after long-term hemodilaysis. Semin Dial 2014;27:57-59. https://doi.org/10.1111/sdi.12154
- Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dial 2008;21:440-446. https://doi.org/10.1111/j.1525-139X.2008.00437.x